“Evaluation of Anti-Inflammatory Effects of Allopurinol in Diabetic Patients with Chronic Kidney Disease (DM-CKD): A Clinical Study”

Mahya Daniyali Shahid Beheshti University of Medical Sciences Leila Mahmoudieh Shahid Labba nejad Medical Center, Shahid Beheshti University of Medical Sciences Golnaz Afzal Shahid Beheshti University of Medical Sciences Farzaneh Hematian Ahvaz Jondishapur University of Medical Sciences Omid Moradi Shahid Beheshti University of Medical Sciences Shadi ziaie (  Shadi_z73@yahoo.com ) Shahid Beheshti University of Medical Sciences

[1]  G. Nichols,et al.  Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes , 2020, BMC Nephrology.

[2]  Zemenu Tamir,et al.  Prevalence and awareness of chronic kidney disease among adult diabetic outpatients in Northeast Ethiopia , 2020, BMC Nephrology.

[3]  M. L. Pedersen.  Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken , 2019, International journal of circumpolar health.

[4]  Baofeng Lian,et al.  The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases , 2019, Journal of Translational Medicine.

[5]  T. Eleftheriadis,et al.  Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review , 2019, Nutrients.

[6]  K. Mutai,et al.  The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening , 2019, BMC Nephrology.

[7]  Khaled A Elhefnawy,et al.  Prevalence of diabetic kidney disease in patients with type 2 diabetes mellitus , 2019, The Egyptian Journal of Internal Medicine.

[8]  M. Sulaiman,et al.  Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management , 2019, Diabetology & Metabolic Syndrome.

[9]  A. Mokdad,et al.  Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. , 2018, Kidney international.

[10]  S. Lai,et al.  Case–control study examining the association between allopurinol use and ischemic cerebrovascular disease , 2018, Journal of Investigative Medicine.

[11]  Ching-Huang Lai,et al.  The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects- An observational study. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[12]  T. Stijnen,et al.  Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  T. Wong,et al.  Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population , 2015, European journal of preventive cardiology.

[14]  J. Navarro-González,et al.  Inflammatory Cytokines in Diabetic Nephropathy , 2015, Journal of diabetes research.

[15]  F. Dekker,et al.  Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients , 2014, BMC Nephrology.

[16]  D. Weiner,et al.  Allopurinol as a Kidney-Protective, Cardioprotective, and Antihypertensive Agent: Hype or Reality? , 2014, Blood Purification.

[17]  Harold I Feldman,et al.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  S. Sezer,et al.  Allopurinol reduces cardiovascular risks and improves renal function in pre-dialysis chronic kidney disease patients with hyperuricemia. , 2014, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[19]  Ghada A. Soliman.  Effect of Vitamin C and / or Vitamin E on Kidney , Liver and brain Functions of Streptozotocin-Induced Diabetic Rats , 2013 .

[20]  Matthew K. Breitenstein,et al.  Association Between Adverse Reactions to Allopurinol and Exposures to High Maintenance Doses: Implications for Management of Patients Using Allopurinol , 2013, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[21]  D. Pašalić,et al.  Uric acid as one of the important factors in multifactorial disorders – facts and controversies , 2012, Biochemia medica.

[22]  M. Goicoechea,et al.  Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[23]  G. Şener,et al.  Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome , 2008, Clinical Research in Cardiology.

[24]  A. Struthers,et al.  High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid , 2006, Circulation.

[25]  K. Iseki,et al.  Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. , 2001, Hypertension research : official journal of the Japanese Society of Hypertension.

[26]  L. Kuller,et al.  Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II , 1990, Diabetes.

[27]  V. Athyros,et al.  Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis. , 2015, The review of diabetic studies : RDS.